The CAHPS survey is coming soon

Jan. 2026Important Notices

The Consumer Assessment of Healthcare Providers and Systems (CAHPS®) survey will be conducted from March through May. This survey gathers feedback from patients about their care experiences and is distributed across all lines of business. The results play a critical role in shaping quality ratings, reimbursement, and patient confidence in their care.

How providers can help

  • Assist with scheduling follow-up appointments promptly and send reminders for upcoming visits.
  • Follow up after referrals or tests to confirm completion and address any lingering questions.
  • Make sure patients and their caregivers end the visit with a clear understanding of any follow-up care or next steps. Provide a printed summary of the visit or direct them to the patient portal.

These simple steps can help improve patient experience and care coordination CAHPS scores, as well as boost positive health outcomes.

CAHPS® 
CAHPS® is a registered trademark of the Agency for Healthcare Research and Quality (AHRQ).

Recent Announcements

Clinical workflow changes through Epic®

Changes are coming for network providers that utilize Provider OnLine to submit specific information to UPMC Health Plan. Select activities that were previously completed in Provider OnLine will now transition to UPMC Health Plan Tapestry Link.
Sep. 2026Important Notices

CME Webinar: Lifestyle Medicine in Practice: Evidence‑Based Strategies for Chronic Disease Care

Please join us for a live, CME-accredited webinar on Wednesday, Sept. 23 from noon to 1 p.m., that will provide an overview on lifestyle medicine. Participants will learn how to integrate six core domains—nutrition, physical activity, sleep, stress management, avoidance of risky substances, and social connection—into routine care using practical tools such as brief counseling, motivational interviewing, and team-based strategies.
Sep. 2026Education/Webinars

Voluntary nationwide recall: Thyroid (Vitruvias – August 2026)

Vitruvias Therapeutics Inc. is recalling one lot, lot 504950, of Thyroid Tablets, USP 30 mg. Thyroid Tablet is used to treat hypothyroidism (underactive thyroid).
Sep. 2026Pharmacy Updates